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Abstract
We examined uptake of rotavirus vaccine and compared trends in acute gastroenteritis (AGE)-
associated hospitalizations and outpatient visits among AI/AN children <5 years of age in the pre- 
and post-rotavirus vaccine era. Rates of AGE-associated hospitalization and outpatient visits 
among AI/AN children remain below prevaccine levels.
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Introduction
Before the introduction of the pentavalent and monovalent rotavirus vaccines (RotaTeq®, 
Merck and Co., New York, New York, and Rotarix®, GSK Biologicals, Brentford, United 
Kingdom, respectively) in the United States in 2006 and 2008, respectively, rotavirus was a 
leading cause of AGE-associated hospitalizations and outpatient visits among children <5 
years of age.[1, 2] Introduction of these vaccines into the routine childhood immunization 
schedule has resulted in declines in healthcare utilization for rotavirus-associated AGE 
among US children.[3–5]
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Infectious acute gastroenteritis, including AGE caused by rotavirus, has been a particular 
public health problem among American Indian/Alaska Native (AI/AN) populations.[6, 7] 
AGE-associated hospitalization rates among AI/AN children were almost twice the rate 
among children in the general United States (US) population in the early 1980s,[6] but by 
the mid-1990s AGE-associated hospitalization rates were similar among AI/AN children and 
US children <5 years of age. However, AGE-associated hospitalization rates among AI/AN 
children <1 year of age remained high when compared to US infant children through the 
mid-2000s.[8] Additionally, AGE-associated outpatient visit rates among AI/AN children <5 
years of age were greater than that among US children.[8]
The Indian Health Service (IHS), the federal agency responsible for providing health 
services to AI/AN people, began using rotavirus vaccine in all IHS areas in 2006. AGE-
associated hospitalization and outpatient visit rates among AI/AN children declined after 
implementation of rotavirus vaccines,[9] but this early examination of vaccine impact on 
AGE-associated hospitalization and outpatient visit rates was limited to the first three years 
after vaccine implementation. To further examine vaccine impact, we examined AGE-
associated hospitalization and outpatient visit rates in the prevaccine era compared with the 
first six years after rotavirus vaccine implementation among AI/AN children <5 years of 
age.
Materials and Methods
The IHS provides health care to AI/ANs through a network of IHS, tribal, and Urban Indian 
health care facilities. Rotavirus vaccination coverage estimates were obtained from the IHS 
Division of Epidemiology and Disease Prevention, which reports vaccination information 
from IHS electronic health records on a quarterly basis.[10] Average rotavirus vaccination 
coverage for the first and second dose of vaccine among infants aged 3–4 months (dose 1) 
and 5–6 months (dose 2) of age were calculated from calendar years 2008 to 2014. Third 
dose coverage was not assessed due to site-to-site differences in the use of RotaTeq® and 
Rotarix®.
AGE-associated hospitalization and outpatient visit data for AI/AN children <5 years of age 
from calendar years 2001 to 2014 were obtained from the IHS National Patient Information 
Reporting System. These data consist of records of hospital discharges and outpatient visits 
to IHS-operated, tribally operated, and community hospitals and clinics as well as health 
services that are contracted with the IHS or specific tribes. As in the previous examination of 
these data, the West region was excluded from the hospitalization analysis due to the lack of 
IHS- or tribally-funded hospitals as well as limitations in contract health service data.[9] 
Data were categorized by age group (<1 year and 1–4 years of age), and time period with 
respect to rotavirus vaccine availability (2001–2006 classified as prevaccine period; 2007 
classified as a transitional year; [3, 4, 9] and 2008–2014 classified as postvaccine period). 
AGE-associated outpatient visits for calendar years 2001–2014 among AI/AN children <5 
years of age were obtained from all regions, including the West region. Hospital discharge 
and outpatient visit records were classified as AGE-associated when one of up to 15 
discharge diagnosis codes matched an International Classification of Diseases, Ninth 
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Revision, Clinical Modification (ICD-9-CM) code list for acute gastroenteritis.[9] Newborn 
birth hospitalizations were excluded in this study.
Annual and average annual hospitalization or outpatient AGE-associated visit rates were 
expressed as the number of hospitalizations or visits per 10,000 AI/AN children <5 years of 
age in the corresponding population. Population denominators for rate calculation estimates 
were identified by using the IHS/tribal user population counts for each age category for 
calendar years 2001–2014; the IHS user population includes all registered AI/AN persons 
who had received IHS-funded health care services at least once in the preceding three years. 
Poisson regression was used to compare rates and test for trends. Statistical significance was 
determined at p-values < 0.05. All analyses were completed using SAS/STAT® software.
Results
Average annual rotavirus vaccine coverage for dose 1 among AI/AN infants 3 to 4 months of 
age and for dose 2 among infants 5 to 6 months of age increased significantly (p<0.05) over 
the study period (Figure 1).
During 2001 through 2014, a total of 7,257 AGE-associated hospitalizations among AI/AN 
children <5 years of age were reported to IHS. The prevaccine (2001–2006) average annual 
AGE-associated hospitalization rate among AI/AN children <5 years of age was 61 per 
10,000 (annual range: 52–78 per 10,000). The rate declined progressively to reach a low of 
24 per 10,000 in 2014, a decrease of 61% (p<0.0001) (Figure 1A). The prevaccine average 
annual AGE-associated hospitalization rate among AI/AN children <1 year of age was 232 
per 10,000 and declined to 80 per 10,000 in 2014, a 66% decrease (p<0.0001).
During 2001 through 2014, a total of 342,188 AGE-associated outpatient visits among 
AI/AN children <5 years of age were reported to IHS. The prevaccine average annual AGE-
associated outpatient visit rate among AI/AN children <5 years of age was 2,188 per 10,000 
(annual range: 2095–2401 per 10,000) and declined to 1,438 per 10,000 in 2014, a decrease 
of 34% (p<0.0001) (Figure 1B). The prevaccine average annual AGE-associated outpatient 
visit rate among AI/AN children <1 year of age was 5,865 per 10,000 and declined to 2,982 
per 10,000 in 2014, a 49% decrease (p<0.0001).
Discussion
We previously highlighted the decrease in AGE-associated hospitalization and outpatient 
visit rates among AI/AN children for the first 3 years following the introduction of rotavirus 
vaccine,[9] and now demonstrate that these decreases have been sustained from 2010–2014.
The sustained declines in AGE-associated hospitalization and outpatient visit rates are likely 
attributable to rotavirus vaccination. The declines in AGE-associated hospitalization were 
found to be more pronounced almost every subsequent year following vaccine introduction, 
as increasing numbers of children were being vaccinated. Additionally, while we observed 
dramatic reductions in AGE-associated hospitalization rates since the introduction of 
rotavirus vaccine, the reduction in AGE-associated outpatient visit rates were more modest. 
This observation provides additional evidence that the introduction of rotavirus vaccine has 
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contributed to the substantial decrease in more severe AGE-associated illness. Rotavirus 
gastroenteritis among children is commonly more severe than that from other causes [1], 
therefore a greater proportion of AGE-associated hospitalizations would be prevented 
through vaccination than the proportion of less severe episodes of gastroenteritis leading to 
outpatient visits.
We estimated that annual AGE-associated hospitalization rates among AI/AN children <5 
years of age declined up to 64% annually compared to 2001–2006. Our estimated 
hospitalization rates are consistent with another study that reported acute gastroenteritis 
hospitalization rates among US children <5 years of age, which ranged between 39 per 
10,000 in 2008 to 27 per 10,000 in 2010,[5] but were somewhat lower than those reported by 
another study that examined hospitalization rates among U.S. children <5 years of age in 24 
states.[4] Additionally, our estimated hospitalization rate reductions are similar or greater to 
the rate reductions (ranging from 25%–55% annually) reported by these studies.
We estimated that annual AGE-associated outpatient visit rates among AI/AN children <5 
years of age declined up to 39% annually compared to 2001–2006. Our estimated AI/AN 
outpatient visit rates are notably higher than those reported among U.S. children <5 years of 
age from 2008 to 2010; in 2014, the estimated AGE-associated outpatient visit rate among 
AI/AN children was 1,438 per 10,000, while the outpatient visit rate among U.S. children <5 
years of age was 1,360 per 10,000 in 2008.[5] However, AGE-associated outpatient visit 
rates decreased more dramatically among AI/AN children when compared to U.S. children 
from 2008–2010.
Our study has some limitations. First, ICD9-coded AGE-associated diagnoses may be 
incomplete or inaccurate. While our results strongly suggest that use of rotavirus vaccine led 
to decreases in AGE-associated hospitalization and outpatient visit rates, we could not 
directly detect any decreases in rotavirus-coded AGE due to the small number of rotavirus-
coded outpatient visits and hospitalizations, and did not directly analyze laboratory-
confirmed rotavirus infections. Additionally, annual trends in other pathogens associated 
with less severe gastroenteritis (e.g., norovirus) would likely affect our findings, particularly 
AGE-associated outpatient visit rates. Furthermore, our ecologic analysis of hospitalization 
and outpatient visit rates is susceptible to variability across IHS regions including host 
factors such as comorbidities; disease factors such as rotavirus strain differences and AGE 
outbreaks; variations in use of vaccines that require two vs. three doses; and social factors 
such as access to health care and variability in physician treatment practices. Finally, AI/AN 
patients within the IHS healthcare system may receive care outside the IHS system, and such 
care episodes would not be included in this study.
Conclusions
Sustained decreases in AGE-associated hospitalization and outpatient rates in the years after 
the introduction of rotavirus vaccine among AI/AN children in the IHS underscores the 
health benefits of vaccination. Continued efforts to increase rotavirus vaccination coverage 
among AI/AN children are expected to further reduce AGE-associated hospitalizations and 
outpatient visits.
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Summary
Decreasing trends in acute gastroenteritis-associated hospitalization and outpatient visit 
rates have been sustained during the seven years following rotavirus vaccine introduction 
within the Indian Health Service. These decreases underscore the importance of 
vaccination uptake among American Indian and Alaska Native children.
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Figure 1. (A) Annual rates of gastroenteritis-associated hospitalizations among AI/AN children 
<5 years of age; (B) Annual rates of gastroenteritis-associated outpatient visits among AI/AN 
children <5 years of age
Note: Prevaccine years (black), transition year (white), and postvaccine years (gray) are 
shown
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